Ignota Labs: $6.9 Million (Seed) Raised For AI-Based Drug Turnaround Company
By Amit Chowdhry ● Mar 7, 2025
Ignota Labs, an AI-based drug turnaround company, announced the closing of a $6.9 million (GBP 5.5 million) seed funding round, co-led by Montage Ventures and AIX Ventures, with participation from Modi Ventures, Blue Wire Capital, and Gaingels. This funding round will expand the pipeline by acquiring additional distressed assets and advancing their first asset, a PDE9A inhibitor, into early-stage clinical trials.